Home \ Expert Opinion \ Mexol®. Important differences from analogues

Mexidol®. Important differences from analogues

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
The expediency of using the original drug
00:40
Differences in the composition of the analogues of the drug Mexidol®, and the original drug

Schukin Ivan Aleksandrovich - Ph.D., Associate Professor of the Department of Neurology, Neurosurgery and Medical Genetics LF RNIMU named after N.I. Pirogov

Announcement:

Original drugs or analogues, what to choose? Why is it worth using the original Mexidol®, not generics? In this video, we will discuss the advantages of the original drug over analogues.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
The expediency of using the original drug
00:40
Differences in the composition of the analogues of the drug Mexidol®, and the original drug

Block of articles on this topic

Original and reproduced drugs: what do the clinician need to know?

Author:
A.V. Schulkin, A.A. Filimonova
FSBEI in the Ryazan State Medical University of the Ministry of Health of Russia, Ryazan, Russia

To the question of the evidence base of neuroprotective therapy: Focus on ethylmethylhydroxypyridine succinate

Authors:
A.I. Kochetkov, N.A. Shatalova, M.V. Klepikova, T.V. Filippova, O.D. Ostroumova
FSBEI DPO “Russian Medical Academy of Continuing Professional Education” of the Ministry of Health of Russia, Moscow

Reproduced drugs: Benefit ratio/risk

Authors:
E.A. Ushkalova ¹ , S.K. Zyryanov ^1.2 , I.A. Gopienko ¹
¹ FGAOU in Russian University of Friendship of Peoples, Moscow;
² GBUZ in Moscow "City Clinical Hospital No. 24 of the Department of Health of the city of Moscow", Moscow

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com